Clinical characteristics of tertiary hospital patients from whom Acinetobacter Calcoaceticus-Acinetobacter Baumannii complex strains were isolated

Internal Medicine

Volumn 51, Issue 1, 2012, Pages 51-57

  Yamada, Koichi ^a   Yanagihara, Katsunori ^a   Araki, Nobuko ^a   Harada, Yosuke ^a   Morinaga, Yoshitomo ^a   Akamatsu, Norihiko ^a   Matsuda, Junichi ^a   Izumikawa, Koichi ^a   Kakeya, Hiroshi ^a   Yamamoto, Yoshihiro ^a   Hasegawa, Hiroo ^a   Kohno, Shigeru ^a,b   Kamihira, Shimeru ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Acinetobacter baumannii; Antibiotics; Pneumonia; Risk factor

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN; QUINOLONE;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER CALCOACETICUS ACINETOBACTER BAUMANNII COMPLEX; ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHRONIC LIVER DISEASE; CLINICAL FEATURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; PNEUMONIA; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84855219444     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6018     Document Type: Article

References (25)

1. Young LS, Sabel AL, Price CS. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hosp Epidemiol 28: 1247-1254, 2007.
2. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 358: 1271-1281, 2008.
3. Maragakis LL, Perl TM. Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46: 1254-1263, 2008.
4. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 42: 692-699, 2006.
5. Rello J, Ulldemolins M, Lisboa T, et al. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 37: 1332-1339, 2011.
6. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 31: 101-106, 2000.
7. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, et al. Acinetobacter baumannii ventilator-associated pneumonia: Epidemiological and clinical findings. Intensive Care Med 31: 649-655, 2005.
8. Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: Risk factors for acquisition, infection and their consequences. J Hosp Infect 65: 204-211, 2007.
9. Carry RB, Banerjee SN, Srinivasan A. Multidrug-resistant Acinetobacter infections, 1995-2004. In: Presented at the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, September. San Francisco, 2006: 27-30.
10. Lockhart SR, Abramson MA, Beekmann SE, et al. Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 45: 3352-3359, 2007.
11. Reddy T, Chopra T, Macchaim D, et al. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agent Chemother 54: 2235-2238, 2010.
12. Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52: 813-821, 2008.
13. Shelburme SA 3rd, Singh KV, White AC Jr, et al. Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas. J Clin Microbiol 46: 198-205, 2008.
14. Brahmi N, Beji O, Abidi N, et al. Epidemiology and risk factors for colonization and infection by Acinetobacter baumannii in an ICU in Tunisia, where this pathogen is endemic. J Infect Chemother 13: 400-404, 2007.
15. Yuji K, Oiso G, Matsumura T, Murashige N, Kami M. Police investigation into multidrug-resistant Acinetobacter baumannii outbreak in Japan. Clin Infect Dis 52: 421, 2011.
16. Magret M, Lisboa T, Martin-Loeches I, et al. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: A prospective and observational multicenter study. Crit Care 15: R62, 2011.
17. Bone C, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655, 1992.
18. Livermore DM, Hope R, Brick G, Lillie M, Reynolds R. Nonsusceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in UK and Ireland, 2001-06. J Antimicrob Chemother 62 (Suppl.2): 55-63, 2008.
19. Ishii Y, Ueda C, Kouyama Y, Tateda K, Yamagichi K. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008). Diagn Microbiol Infect Dis 69: 443-448, 2011.
20. Tseng YC, Wang JT, Wu FL, Chen YC, Chie WC, Chang SC. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 59: 181-190, 2007.
21. Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest 120: 1072-1077, 2001.
22. Dent LL, Marshall DR, Pratap S, Hulette R. Multidrug resistant Acinetobacter baumannii: A descriptive study in a city hospital. BMC Infect Dis 10: 196, 2010.
23. Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification. J Clin Microbiol 29: 277-282, 1991.
24. Chuang YC, Sheng WH, Li SY, et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin Infect Dis 52: 352-360, 2011.
25. Lee NY, Chang TC, Wu CJ, et al. Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia. J Infect 61: 219-227, 2010.